[
    [
        {
            "time": "",
            "original_text": "西南证券维持上海医药买入评级，2021年半年报点评：业绩增长超预期，创新药研发进程加速",
            "features": {
                "keywords": [
                    "上海医药",
                    "买入评级",
                    "业绩增长",
                    "创新药",
                    "研发进程"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "西南证券维持上海医药买入评级，2021年半年报点评：业绩增长超预期，创新药研发进程加速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "云南白药(000538)：聚焦主业 主营业绩大幅增长",
            "features": {
                "keywords": [
                    "云南白药",
                    "聚焦主业",
                    "主营业务",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "云南白药(000538)：聚焦主业 主营业绩大幅增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "西南证券：维持上海医药(601607.SH)“买入”评级 业绩增长超预期 创新药研发进程加速",
            "features": {
                "keywords": [
                    "西南证券",
                    "上海医药",
                    "买入评级",
                    "业绩增长",
                    "创新药",
                    "研发进程"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "西南证券：维持上海医药(601607.SH)“买入”评级 业绩增长超预期 创新药研发进程加速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "港股盘前必读：打击无牌加密货币，贝壳计划筹资20亿美元赴港上市",
            "features": {
                "keywords": [
                    "港股",
                    "加密货币",
                    "贝壳",
                    "筹资",
                    "赴港上市"
                ],
                "sentiment_score": -0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "房地产"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股盘前必读：打击无牌加密货币，贝壳计划筹资20亿美元赴港上市",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "瑞信：下调上海医药(02607.HK)目标价至18港元 评级降至中性 机构下调估值",
            "features": {
                "keywords": [
                    "瑞信",
                    "上海医药",
                    "目标价",
                    "评级",
                    "中性",
                    "下调估值"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "瑞信：下调上海医药(02607.HK)目标价至18港元 评级降至中性 机构下调估值",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]